Importance of the new triazoles in antifungal therapy
dc.authorscopusid | 7003291643 | |
dc.contributor.author | Durmaz B. | |
dc.date.accessioned | 2024-08-04T19:59:26Z | |
dc.date.available | 2024-08-04T19:59:26Z | |
dc.date.issued | 1991 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.endpage | 123 | en_US |
dc.identifier.issn | 0374-9096 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 1652677 | en_US |
dc.identifier.scopus | 2-s2.0-0025922692 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 118 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/90631 | |
dc.identifier.volume | 25 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | tr | en_US |
dc.relation.ispartof | Mikrobiyoloji Bulteni | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | fluconazole | en_US |
dc.subject | itraconazole | en_US |
dc.subject | ketoconazole | en_US |
dc.subject | natamycin | en_US |
dc.subject | nystatin | en_US |
dc.subject | antifungal agent | en_US |
dc.subject | drug derivative | en_US |
dc.subject | fluconazole | en_US |
dc.subject | itraconazole | en_US |
dc.subject | ketoconazole | en_US |
dc.subject | antibiotic sensitivity | en_US |
dc.subject | aspergillus | en_US |
dc.subject | candida albicans | en_US |
dc.subject | cryptococcus neoformans | en_US |
dc.subject | review | en_US |
dc.subject | human | en_US |
dc.subject | mycosis | en_US |
dc.subject | Antifungal Agents | en_US |
dc.subject | English Abstract | en_US |
dc.subject | Fluconazole | en_US |
dc.subject | Human | en_US |
dc.subject | Itraconazole | en_US |
dc.subject | Ketoconazole | en_US |
dc.subject | Mycoses | en_US |
dc.title | Importance of the new triazoles in antifungal therapy | en_US |
dc.type | Review Article | en_US |